Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 16-May 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 106630601000001116 | Carbocisteine 125mg/5ml oral solution (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 106630701000001114 | Carbocisteine 125mg/5ml oral solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carbocisteine 125mg/5ml oral solution | Is a | Product containing carbocisteine | false | Inferred relationship | Existential restriction modifier | ||
| Carbocisteine 125mg/5ml oral solution | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Carbocisteine 125mg/5ml oral solution | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Carbocisteine 125mg/5ml oral solution | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
| Carbocisteine 125mg/5ml oral solution | Has active ingredient | Carbocisteine | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mucodyne Paediatric 125mg/5ml syrup (Beacon Pharmaceuticals Ltd) | Is a | False | Carbocisteine 125mg/5ml oral solution | Inferred relationship | Existential restriction modifier | |
| Carbocisteine 125mg/5ml oral solution 300 ml | Has VMP | False | Carbocisteine 125mg/5ml oral solution | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR